University of Maryland, Baltimore;Tokai Pharmaceuticals, Inc.;University of Washington
发明人:
Jacoby, Douglas,Njar, Vincent,Zoubeidi, Amina,Ferrante, Karen,Corey, Eva
申请号:
AU2014306698
公开号:
AU2014306698A1
申请日:
2014.08.12
申请国别(地区):
AU
年份:
2016
代理人:
摘要:
Described herein are methods and compositions for the treatment of prostate cancer in a subject in need thereof. The prostate cancer may be a castration resistant and an androgen receptor antagonist-resistant prostate cancer. The methods may comprise administering to the subject a CYP17-lyase inhibitor of Formula II.